STEM CELLS TEST - RECOMMENDATION OF ECVAM FOR CHEMICAL TESTING WITH CONSEQUENCE IN HEALTH RISK ASSESSMENT

Authors

  • Daniela CIORBA Babeş-Bolyai University, Faculty of Environmental Science and Engineering, 30 Fântânele St., 400294, Cluj-Napoca, Romania. *Corresponding author: ciorbad@yahoo.com https://orcid.org/0000-0002-1240-3865

DOI:

https://doi.org/10.24193/subbambientum.2019.2.01

Keywords:

stem cells, alternative methods, chemical testing.

Abstract

The introduction of stem cells in environmental health studies could mean an important step in health risk assessment. It may be all the more important as we attend to increase the environmental influences to disease -associated epigenetic changes among adults, but especially for children. The assessment of health risk requires testing of environmental chemicals which they continued to need more time in animal studies. The stem cells -human models, increase the rate of testing, that does not require dose translation across species. Validation of environmental exposure will be done for very large interval data, for many chemicals or "chemicals cocktails" at much lower costs.

References

Ahr H.J., Alepée N., Breier S., Brekelmans C., Cotgreave I., Gribaldo L., Negro G.D., De Silva O., Hartung T., Lacerda A., Leblanc B., Lecerf C., Linge J.P., Louhimies S., Manou I., Maxwell G., Müller K.K., Pape W., Redhead K., Schröder K.R., Sladowski D., Van der Jagt K., Vanparys P., 2008, Barriers to Validation: A Report by European Partnership for Alternative Approaches to Animal Testing (EPAA) Working Group 5a. Alternatives to Laboratory Animals, 36 (4), pp. 459-464.

Aiba K., Nedorezov T., Piao Y., Nishiyama A., Matoba R., Sharova L.V., Sharov A.A., Yamanaka S., Niwa H., Ko M.S., 2009, Defining developmental potency and cell lineage trajectories by expression profiling of differentiating mouse embryonic stem cells. DNA Research, 16 (1), pp. 73–80.

Betts K.S., 2010, Using Stem Cells to Study Developmental Neurotoxicology. Environmental Health Perspectives, 118 (1), pp. 433-437.

Casado F.L., Singh K.P., Gasiewicz T.A., 2011, Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Molecular Pharmacology Fast Forward, 80 (4), pp. 673–682.

Cieślar-Pobuda A., Yue J., Lee H.C., Skonieczna M., Wei Y.H., 2017, ROS and Oxidative Stress in Stem Cells. Oxid Med Cell Longev, Article ID 5047168, DOI: 10.1155/2017/5047168.

Dolmetsch R., Geschwind D.H., 2011, The human brain in a dish: the promise of iPSC-derived neurons. Cell., 145 (6), pp. 831–834.

EPA Web Archive, January 19, 2017, Toxicity Forecasting, Advancing the Next Generation of Chemical Evaluation.

Gasiewicz TA.,Singh KP., Cassado FL., 2017, Aryl Hydrocarbon Receptor and Stem Cells, Hidawi Stem Cell International, Volume 2017, Article ID 4602854, https://doi.org/10.1155/2017/4602854

Karouzakis E., Rengel Y., Jungel A. et al., 2011, DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun, 12, pp. 643–652.

NRC (National Research Council), 2007, Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council: Toxicity Testing in the 21st Century: A Vision and a Strategy. The national academies press. 196 p. Available at http://www.nap.edu/catalog.php?record_id=11970, accessed on February 2020.

Ospelt C., Gay S., 2014, Epigenetics in inflammatory systemic diseases. Der Internist, 55 (2), pp. 124-127.

Paquette J.A., Kumpf S.W., Streck R.D., Thomson J.J., Chapin R.E., Stedman D.B., 2008, Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry. Birth Defects Res. B Dev. Reprod. Toxicol., 83, pp. 104-111.

Thomas R.T., Paules R.S., Simeonov A., Fitzpatrick S., Crofton K., Casey W., Mendrick D., 2018, The US Federal Tox21 Program: A Strategic and Operational Plan for Continued Leadership. ALTEX, 35 (2), pp. 163-168.

Yazawa M., Hsueh B., Jia X., Pasca A.M., Bernstein J.A., Hallmayer J., Dolmetsch R.E., 2011, Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature, 471 (7337), pp. 230-234.

Downloads

Published

2019-12-30

How to Cite

CIORBA, D. (2019). STEM CELLS TEST - RECOMMENDATION OF ECVAM FOR CHEMICAL TESTING WITH CONSEQUENCE IN HEALTH RISK ASSESSMENT. Studia Universitatis Babeș-Bolyai Ambientum, 64(2), 5–10. https://doi.org/10.24193/subbambientum.2019.2.01

Issue

Section

Articles

Most read articles by the same author(s)